The Mammalian Cell Fermentation Technology Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The market size of the Mammalian Cell Fermentation Technology has been expanding rapidly over recent years. It is expected to increase from $51.29 billion in 2024 to $57.48 billion in 2025, with a compound annual growth rate (CAGR) of 12.1%.
The mammalian cell fermentation technology market is forecasted to reach a value of $89.54 billion in 2029, growing at a compound annual growth rate (CAGR) of 11.7%.
Download Your Free Sample of the 2025 Mammalian Cell Fermentation Technology Market Report and Uncover Key Trends Now!The drivers in the mammalian cell fermentation technology market are:
• Increased demand for biologics and biosimilars
• Rising focus on personalized medicine
• Growing production of biopharmaceuticals
• Increased need for scalable and effective cell culture methods
The mammalian cell fermentation technology market covered in this report is segmented –
1) By Type: Chinese Hamster Ovary Cell Fermentation, Human Embryonic Kidney Cell Fermentation, Baby Hamster Kidney Cell Fermentation, Murine Myeloma Cell Fermentation, Other Types
2) By Application: Monoclonal Antibodies, Recombinant Proteins, Vaccines, Hormones, Enzymes, Other Applications
3) By End-Use: Biopharmaceutical Companies, Contract Research Organizations And Contract Development and Manufacturing Organizations, Academic And Research Institutes
The trends in the mammalian cell fermentation technology market are:
• Technological advancements in cell culture techniques are a major emerging trend.
• Innovations in bioreactor design are shaping the market future.
• The development of next-generation bioprocessing technologies is an upcoming trend.
• The integration of multi-omics approaches and technology-driven automation also drive the market.
The major players in the mammalian cell fermentation technology market are:
• Major players in the mammalian cell fermentation technology market include AbbVie Inc.
North America was the largest region in the mammalian cell fermentation technology market in 2024